Role of rosiglitazone in lipopolysaccharide-induced peritonitis: A rat peritoneal dialysis model

被引:7
|
作者
Song, Sang Heon [1 ,2 ]
Kwak, Ihm Soo [1 ,2 ]
Yang, Byeong Yun [1 ,2 ]
Lee, Dong Won [1 ,2 ]
Lee, Soo Bong [1 ,2 ]
Lee, Min Young [2 ]
机构
[1] Pusan Natl Univ Hosp, Dept Internal Med, Pusan 602739, South Korea
[2] Pusan Natl Univ Hosp, Med Res Inst, Pusan 602739, South Korea
关键词
peritoneal dialysis; peritonitis; peroxisome proliferator-activated receptor-gamma; ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; MESOTHELIAL CELLS; DOWN-REGULATION; EXPRESSION; ALPHA; DIFFERENTIATION; AGONIST; DISEASE; INJURY;
D O I
10.1111/j.1440-1797.2008.01037.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim: The aim of this study was to demonstrate the efficacy of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist, rosiglitazone, in the amelioration or prevention of inflammation including peritoneal fibrosis secondary to the peritonitis in a peritoneal dialysis (PD) model of non-uraemic rats. Methods: Thirty male Sprague-Dawley rats were assigned to six groups according to treatment. A 90 min peritoneal equilibrium test, dialysate cellular components, peritoneal thickness and cellularity were assessed on day 21. Additionally, immunohistochemical stains of peritoneal membrane, such as PPAR-gamma, vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-beta 1, collagen-1 and monocyte chemoattractant protein-1 were performed Results: The dialysate neutrophil count and peritoneal thickness in the high-dose rosiglitazone group was significantly decreased compared to the lipopolysaccharide (LPS)-only group. The peritoneal membrane from the LPS-only group showed marked cellular proliferation in the area of the submesothelial compact zone compared with the PD-only group, the rosiglitazone-only group, and the high-dose rosiglitazone group. The 90 min peritoneal equilibrium test (PET) results showed no statistical difference among the six groups excluding dialysate-to-plasma urea ratio. The number of PPAR-gamma expressing cells and the expression of TGF-beta 1 were decreased in the high-dose rosiglitazone group compared to the LPS-only group. There were no differences in the expression of VEGF and collagen-1 among the six groups. Interestingly, the number of PPAR-gamma-positive cells was correlated with expression of VEGF, TGF-beta 1, collagen-1 and monocyte chemoattractant protein-1 irrespective of the study group. Conclusion: The results of this study showed that rosiglitazone ameliorated peritoneal inflammation induced by LPS and reduced the TGF-beta 1 expression in the peritoneal membranes.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 50 条
  • [21] Unveiling risk factors: a prognostic model of frequent peritonitis in peritoneal dialysis patients
    Xu, Qi-jiang
    Zang, Zhi-yun
    Zhou, Xue-li
    Ma, Ni-ya
    Pu, Li
    Li, Zi
    FRONTIERS IN MEDICINE, 2025, 12
  • [22] Successful antibiotic treatment of Pseudomonas stutzeri-induced peritonitis without peritoneal dialysis catheter removal in continuous ambulatory peritoneal dialysis
    Park, Sung Wook
    Back, Ji Hyeon
    Lee, Seoung Woo
    Song, Joon Ho
    Shin, Chun Ho
    Kim, Gyung Eun
    Kim, Moon-Jae
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2013, 32 (02) : 81 - 83
  • [23] Zymosan, but Not Lipopolysaccharide, Triggers Severe and Progressive Peritoneal Injury Accompanied by Complement Activation in a Rat Peritonitis Model
    Mizuno, Masashi
    Ito, Yasuhiko
    Hepburn, Natalie
    Mizuno, Tomohiro
    Noda, Yukihiro
    Yuzawa, Yukio
    Harris, Claire L.
    Morgan, B. Paul
    Matsuo, Sefchi
    JOURNAL OF IMMUNOLOGY, 2009, 183 (02) : 1403 - 1412
  • [24] Heat Shock Protein 72 Enhances Autophagy as a Protective Mechanism in Lipopolysaccharide-Induced Peritonitis in Rats
    Li, Shu
    Zhou, Yi
    Fan, Jinjin
    Cao, Shirong
    Cao, Tao
    Huang, Fengxian
    Zhuang, Shougang
    Wang, Yihan
    Yu, Xueqing
    Mao, Haiping
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 179 (06) : 2822 - 2834
  • [25] Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis
    Yun-Fang Zhang
    Xun-Liang Zou
    Jun WU
    Xue-Qing Yu
    Xiao Yang
    Inflammation, 2015, 38 : 2105 - 2115
  • [26] Cat induced Pasteurella multocida peritonitis in peritoneal dialysis: A case report and review of the literature
    Sol, Patricia M.
    van de Kar, Nicole C. A. J.
    Schreuder, Michiel F.
    INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2013, 216 (02) : 211 - 213
  • [27] Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy
    Nakao, Ai
    Nakao, Kazushi
    Takatori, Yuji
    Kojo, Syoichirou
    Inoue, Junko
    Akagi, Shigeru
    Sugiyama, Hitoshi
    Wada, Jun
    Makino, Hirofumi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (05) : 1479 - 1488
  • [28] Construction and validation of a predictive model for the risk of peritoneal dialysis-associated peritonitis after peritoneal dialysis catheterization
    Dai, Rong
    Peng, Chuyi
    Sang, Tian
    Cheng, Meng
    Wang, Yiping
    Zhang, Lei
    FRONTIERS IN MEDICINE, 2023, 10
  • [29] Timely diagnosis and management of Quambalaria cyanescens-induced peritoneal dialysis peritonitis: A rare case highlighting the role of galactomannan testing
    Somtha, Baramett
    Tianprasertkij, Kanjana
    Promngam, Supattra
    Saejew, Thunvarat
    Kanjanabuch, Talerngsak
    MEDICAL MYCOLOGY CASE REPORTS, 2025, 47
  • [30] THE ROLE OF NGAL IN PERITONEAL DIALYSIS EFFLUENT IN EARLY DIAGNOSIS OF PERITONITIS: CASE-CONTROL STUDY IN PERITONEAL DIALYSIS PATIENTS
    Martino, Francesca
    Scalzotto, Elisa
    Giavarina, Davide
    Rodighiero, Maria Pia
    Crepaldi, Carlo
    Day, Sonya
    Ronco, Claudio
    PERITONEAL DIALYSIS INTERNATIONAL, 2015, 35 (05): : 559 - 565